Achieve Life Sciences
ACHV
81 hedge funds and large institutions have $63.6M invested in Achieve Life Sciences in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 11 closing their positions.
1,628% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $145K
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
5% more funds holding
Funds holding: 77 → 81 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.22% less ownership
Funds ownership: 43.66% → 40.43% (-3.2%)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
45% less capital invested
Capital invested by funds: $115M → $63.6M (-$51.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Lakeside Advisors
Seattle,
Washington
|
+$493K |
| 2 |
LPL Financial
San Diego,
California
|
+$423K |
| 3 |
BHCM
Brevan Howard Capital Management
St. Helier,
Jersey
|
+$242K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$207K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pathstone Holdings
Englewood,
New Jersey
|
-$1.86M |
| 2 |
Goldman Sachs
New York
|
-$1.32M |
| 3 |
Millennium Management
New York
|
-$1.25M |
| 4 |
Jane Street
New York
|
-$913K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$745K |
ACHV Hedge Fund Activity: Q1 2026 in Review
81 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2026, worth a combined $63.6M — down 45% from $115M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ACHV positions and 11 closed out — a net gain of 6 holders — while 17 added to existing stakes and 23 trimmed.
The largest buyer was Lakeside Advisors, opening a new position worth an estimated $493K. The largest seller was Pathstone Holdings, exiting entirely with an estimated $1.86M sold.
- 81 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2026, up from 77 in Q4 2025.
- Funds reported $63.6M of Achieve Life Sciences stock for Q1 2026, down 45% quarter-over-quarter.
- 17 funds opened new Achieve Life Sciences positions in Q1 2026 and 11 closed out, a net change of +6 holders.
- The largest Achieve Life Sciences buyer in Q1 2026 was Lakeside Advisors, an estimated $493K added.
- The largest Achieve Life Sciences seller in Q1 2026 was Pathstone Holdings, an estimated $1.86M sold.
Based on aggregated 13F filings for Q1 2026.